These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1380558)

  • 1. Prenatal biochemical screening.
    Drugan A; O'Brien JE; Gambino RS; Evans MI
    J Reprod Med; 1992 May; 37(5):403-9. PubMed ID: 1380558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum screening.
    Carroll JC
    Can Fam Physician; 1994 Oct; 40():1756-64. PubMed ID: 7524838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of the screening of maternal serum factors for the prenatal diagnosis of fetal developmental defects and chromosomal diseases].
    Arbuzova SB; Nikolenko MI
    Tsitol Genet; 1995; 29(4):44-7. PubMed ID: 8604526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Maternal serum screening for detection of fetal chromosome abnormalities].
    Holzgreve W; Miny P; Schloo R; Tercanli S
    Gynakologe; 1995 Oct; 28(5):280-8. PubMed ID: 7498824
    [No Abstract]   [Full Text] [Related]  

  • 6. Contemporary approaches to prenatal diagnosis.
    Kuller JA; Laifer SA
    Am Fam Physician; 1995 Dec; 52(8):2277-83, 2285-6. PubMed ID: 7484721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis using the triple test.
    Palka G; Guanciali Franchi P; Papponetti M; Marcuccitti J; Morizio E; Calabrese G; Stuppia L; Di Ilio C
    Minerva Ginecol; 1998 Oct; 50(10):411-5. PubMed ID: 9866951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum screening for birth defects: results of a Connecticut regional program.
    Benn PA; Horne D; Craffey A; Collins R; Ramsdell L; Greenstein R
    Conn Med; 1996 Jun; 60(6):323-7. PubMed ID: 8706425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of trisomy 21 risk by serial determination of chorionic gonadotrophin hormone and alpha-fetoprotein: results of a national pilot study].
    Aymé S; Aurran Y; Chabal F; Gombert A; Loundou H; Montfort C; Sollier M; Silvestri A
    Contracept Fertil Sex; 1993 Feb; 21(2):133-43. PubMed ID: 7524931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
    Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC
    Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of congenital anomalies at birth among offspring of women at risk for a genetic disorder and with a normal second-trimester ultrasound.
    Lemyre E; Infante-Rivard C; Dallaire L
    Teratology; 1999 Oct; 60(4):240-4. PubMed ID: 10508977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum screening for fetal trisomy 18: benefits of patient-specific risk protocol.
    Hogge WA; Fraer L; Melegari T
    Am J Obstet Gynecol; 2001 Aug; 185(2):289-93. PubMed ID: 11518881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum screening of Palestinian women in the West Bank.
    Husseini A; Akkawi M
    East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol.
    Heyl PS; Miller W; Canick JA
    Obstet Gynecol; 1990 Dec; 76(6):1025-31. PubMed ID: 1700348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
    Rose NC; Mennuti MT
    West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
    Huang T; Owolabi T; Summers AM; Meier C; Wyatt PR
    Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal maternal serum profiles.
    Spencer K
    Br J Hosp Med; 1994 Mar 2-15; 51(5):243-6. PubMed ID: 7518729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.